XHS vs. PBPH
XHS (SPDR S&P Health Care Services ETF) and PBPH (Portfolio Building Block World Pharma and Biotech Index ETF) are both Health & Biotech Equities funds - XHS tracks the S&P Health Care Services Select Industry Index while PBPH tracks the BITA Global Pharma and Biotech Select Index. Both are passively managed. At a 0.28 correlation, their price movements are largely independent. XHS charges 0.35%/yr vs 0.13%/yr for PBPH.
Performance
XHS vs. PBPH - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, XHS achieves a 6.32% return, which is significantly higher than PBPH's -1.13% return.
XHS
- 1D
- 0.28%
- 1M
- 2.77%
- YTD
- 6.32%
- 6M
- 5.39%
- 1Y
- 16.58%
- 3Y*
- 8.47%
- 5Y*
- 0.44%
- 10Y*
- 7.46%
PBPH
- 1D
- 0.58%
- 1M
- 0.07%
- YTD
- -1.13%
- 6M
- -0.02%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
XHS vs. PBPH - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
XHS SPDR S&P Health Care Services ETF | 6.32% | -3.80% |
PBPH Portfolio Building Block World Pharma and Biotech Index ETF | -1.13% | 0.76% |
Correlation
The correlation between XHS and PBPH is 0.28, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Nov 26, 2025 | 0.28 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
XHS vs. PBPH — Risk / Return Rank
XHS
PBPH
XHS vs. PBPH - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for SPDR S&P Health Care Services ETF (XHS) and Portfolio Building Block World Pharma and Biotech Index ETF (PBPH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| XHS | PBPH | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | 1.18 | — | — |
| Calmar ratioReturn relative to maximum drawdown | 1.39 | — | — |
| Martin ratioReturn relative to average drawdown | 3.83 | — | — |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| XHS | PBPH | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.95 | — | — |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.02 | — | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.33 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.57 | -0.04 | +0.61 |
Drawdowns
XHS vs. PBPH - Drawdown Comparison
The maximum XHS drawdown since its inception was -39.32%, which is greater than PBPH's maximum drawdown of -11.10%. Use the drawdown chart below to compare losses from any high point for XHS and PBPH.
Loading charts...
Drawdown Indicators
| XHS | PBPH | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -39.32% | -11.10% | -28.22% |
Max Drawdown (1Y)Largest decline over 1 year | -11.99% | — | — |
Max Drawdown (3Y)Largest decline over 3 years | -17.81% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -32.62% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -39.32% | — | — |
Current DrawdownCurrent decline from peak | -1.78% | -8.69% | +6.91% |
Average DrawdownAverage peak-to-trough decline | -10.20% | -4.23% | -5.97% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.33% | — | — |
Volatility
XHS vs. PBPH - Volatility Comparison
Loading charts...
Volatility by Period
| XHS | PBPH | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 4.80% | — | — |
Volatility (6M)Calculated over the trailing 6-month period | 11.86% | — | — |
Volatility (1Y)Calculated over the trailing 1-year period | 17.56% | 16.78% | +0.78% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 21.10% | 16.78% | +4.32% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 22.40% | 16.78% | +5.62% |
XHS vs. PBPH - Expense Ratio Comparison
XHS has a 0.35% expense ratio, which is higher than PBPH's 0.13% expense ratio.
Dividends
XHS vs. PBPH - Dividend Comparison
XHS's dividend yield for the trailing twelve months is around 0.25%, more than PBPH's 0.09% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PBPH Portfolio Building Block World Pharma and Biotech Index ETF | 0.09% | 0.09% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
XHS SPDR S&P Health Care Services ETF | 0.25% | 0.27% | 0.38% | 0.23% | 0.19% | 0.20% | 0.23% | 2.37% | 0.34% | 0.22% | 0.28% | 0.93% |
Frequently Asked Questions
XHS and PBPH have a correlation of 0.28, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, PBPH is cheaper at 0.13% per year. The better choice depends on whether you care most about return, fees, risk, or income.
PBPH is cheaper with a 0.13% expense ratio, compared with 0.35% for XHS.
XHS has the higher dividend yield at 0.25%, compared with 0.09% for PBPH.
XHS tracks S&P Health Care Services Select Industry Index, while PBPH tracks BITA Global Pharma and Biotech Select Index. They also come from different issuers: State Street and Portfolio Building Block. Their fees differ too: 0.35% for XHS and 0.13% for PBPH.
Find the right allocation for XHS and PBPH
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer